Bioventus Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
BVS Nasdaq 3841 http://www.bioventus.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioventus Inc

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration - Oct 18th, 2021 12:00 pm
Bragar Eagel & Squire, P.C. Announces that it Is Investigating the Boards of Directors of Sanderson Farms, Misonix, and Steadfast Apartment REIT on behalf of Stockholders and Encourages Investors to Contact the Firm - Oct 1st, 2021 8:51 pm
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Misonix, Inc. (Nasdaq - MSON) - Sep 24th, 2021 7:45 pm
DUROLANE® Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons - Sep 20th, 2021 12:30 pm
Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results - Sep 2nd, 2021 8:01 pm
Bioventus Proceeds with Option Structure Agreement with CartiHeal - Aug 30th, 2021 11:30 am
Bioventus Invests in Trice Medical Minimally Invasive Technologies - Aug 25th, 2021 8:05 pm
Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer - Aug 23rd, 2021 12:30 pm
SV Health Investors Announces Three Realizations in its Growth Equity Portfolio - Aug 19th, 2021 10:30 am
Will a Powerful Acquisition Make This Early 2021 IPO a Buy? - Aug 17th, 2021 11:49 am
Bioventus Inc. (BVS) Q2 2021 Earnings Call Transcript - Aug 11th, 2021 7:01 am
Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance - Aug 10th, 2021 8:05 pm
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Misonix, Inc. Buyout - Jul 30th, 2021 10:06 pm
MISONIX ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MSON and Encourages Investors to Contact the Firm - Jul 30th, 2021 6:59 pm
Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix - Jul 29th, 2021 8:05 pm
Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results - Jul 29th, 2021 8:01 pm
Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance - Jul 29th, 2021 8:00 pm
Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference - Jul 27th, 2021 8:15 pm
Bioventus Appoints Mary Kay Ladone to Board of Directors - Jul 14th, 2021 8:05 pm
Bioventus Launches OSTEOAMP® SELECT Flowable Nationwide - Jul 13th, 2021 12:30 pm